Tender notice · Contracts Finder
Framework for the Ongoing Supply of Plasmid
Part of Framework for the Ongoing Supply of Plasmid.
In response to the COVID-19 Vaccine manufacture programme, CPI need to secure supply of linearised plasmid to help develop a self-amplifying RNA Vaccine. This tender is split into three lots: 1. To generate and validate a MCB for plasmid production, starting with a provided plasmid template in an appropriate strain of E. coli. 2. From the MCB, supply 10g of purified linearised plasmid manufactured according to GMP.(To simplify the tendering process, CPI will free issue the restriction enzyme for linearization to the successful bidder) 3. Provision of the combined services of Lot 1 and 2.
- Procurement
- Framework for the Ongoing Supply of Plasmid
- Published
- 26 Jun 2020
- Status
- active
- CPV
- 33600000 — Pharmaceutical products
- Tender period
- — – 10 Jul 2020
Other notices in this procurement
This is the only notice on record.
FAQs about this notice
What type of notice is this?
This is a tender notice published via Contracts Finder on 26 Jun 2020.
Which procurement does this notice belong to?
It is part of "Framework for the Ongoing Supply of Plasmid", published by CENTRE FOR PROCESS INNOVATION LIMITED.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable